Gujarat Kidney And Super Speciality LimitedGKSLCorporate

Hospital Latest results: Jun 2026 2 quarters of data

₹187.37

MCap ₹1,477 Cr

Gujarat Kidney And Super Speciality Limited — Stock analysis & AI research Gujarat Kidney And Super Speciality Limited — Multibagger AI analysis Gujarat Kidney And Super Speciality Limited — Seasonality — best & worst months Gujarat Kidney And Super Speciality Limited — Technical setup — score, trend, support & resistance Gujarat Kidney And Super Speciality Limited — Live exchange announcements

📈 Strong Trend Stocks (ADX > 25)📈 Relative Strength Leaders 🏭 Healthcare sector

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹34 Cr

Sales · Jun 2026

₹8 Cr

Operating Profit · Jun 2026

24.4%

OPM % · Jun 2026

₹5 Cr

Net Profit · Jun 2026

₹0.66

EPS · Jun 2026

📝 Gujarat Kidney And Super Speciality Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Gujarat Kidney And Super Speciality Limited reported revenue of ₹34 crore for the quarter ended June 2026 (Q1 FY27).

Net profit stood at ₹5 crore. Earnings per share (EPS) came in at ₹0.66.

Operating profit stood at ₹8 crore — an operating margin (OPM) of 24.4%.

Valuation snapshot

At the current price of ₹187.37, GKSL has a market capitalisation of ₹1,477 crore.

Within the Hospital industry, it is the 4th-largest of the 10 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 71.45%, foreign institutional investors (FIIs) 6.53%, domestic institutional investors (DIIs) 0.26%, public shareholders 21.77% of Gujarat Kidney And Super Speciality Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹1,477 Cr

Current Price ?

₹187.4

P/E ?

N/A

Industry P/E ?

39.60

P/B ?

N/A

P/S ?

N/A

P/FCF ?

N/A

Enterprise Value ?

N/A

EV/EBITDA ?

N/A

PEG ?

N/A

Earnings Yield ?

N/A

Dividend Yield ?

N/A

Profitability & Returns

Sales (TTM) ?

N/A

OPM ?

N/A

Profit after tax (TTM) ?

N/A

EPS (TTM) ?

N/A

ROCE ?

N/A

ROE ?

N/A

ROA ?

N/A

Growth

Sales — latest qtr ?

₹34 Cr

PAT — latest qtr ?

₹5 Cr

YoY qtr sales growth ?

N/A

YoY qtr profit growth ?

N/A

Sales growth (3y) ?

N/A

Sales growth (5y) ?

N/A

Profit growth (3y) ?

N/A

Profit growth (5y) ?

N/A

Financial Health

Debt ?

N/A

Debt to Equity ?

N/A

Interest Coverage ?

N/A

Current Ratio ?

N/A

Ownership

Promoter holding ?

71.45%

Change in promoter holding ?

0.00%

Pledged percentage ?

N/A

Market

Return 3 months ?

46.0%

Return 6 months ?

66.9%

🗓️ Quarterly results (2 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Dec 2025	Jun 2026	YoY %	QoQ %
Sales	13	34	—	—
Operating Profit	5	8	—	—
Other Income	0	1	—	—
Interest	0	1	—	—
Depreciation	1	1	—	—
Profit Before Tax	4	7	—	—
Net Profit	3	5	—	—
EPS	—	0.66	—	—
OPM %	39.6%	24.4%	—	—

📆 Annual results (₹ Cr, FY = Apr–Mar)

Annual rollup not yet available We need at least 3 quarters of a fiscal year to compute annual figures. This symbol does not yet have a complete fiscal year in our database.

👥 Shareholding (latest 2 periods)

Metric	Jun 2026	Sep 2026	% Chg
Promoters	71.45%	71.45%	+0.0%
FIIs	4.88%	6.53%	+33.8%
DIIs	0.56%	0.26%	-53.6%
Public	23.10%	21.77%	-5.8%
No. of Shareholders	18,301	12,986	-29.0%

⚖️ Peer comparison

Industry: Hospital · 10 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	PARKHOSPS Park Medi	₹280.90	12,133	42.4	1,756	298	26.5%	16.9%	—	—	19.3%	34.8%
2	526783 Dr Agarwals	₹5,253.00	2,465	33.3	497	75	30.4%	15.2%	18.6%	27.8%	22.2%	37.5%
3	524520 KMC Speciality	₹81.32	2,373	23.8	331	57	30.4%	17.1%	32.5%	108.7%	37.0%	107.2%
4	GKSL Gujarat Kidney	₹172.33	1,359	—	—	—	—	—	—	—	—	—
5	543346 Aashka Hospitals	₹117.80	195	83.0	23	3	22.8%	14.5%	—	—	22.3%	55.2%
6	531658 Abate As	₹28.64	120	266.9	—	2	—	—	—	158.6%	—	10.1%
7	523696 Fortis Malar	₹65.66	79	n/m	0	0	-5165.0%	427.8%	—	932.5%	-95.5%	-96.3%
8	544013 KK Shah	₹49.79	30	—	9	-1	8.2%	-6.6%	—	—	-7.2%	57.1%
9	539378 Soni Medicare	₹26.49	30	—	23	-4	-8.1%	-15.5%	-15.9%	-1405.6%	-39.2%	-313.3%
10	543520 Global Longlife	₹30.99	16	—	—	-2	—	—	—	—	—	61.5%

❓ Frequently asked questions

What was Gujarat Kidney And Super Speciality Limited's revenue in Q1 FY27?

Gujarat Kidney And Super Speciality Limited reported revenue of ₹34 crore for the quarter ended June 2026 (Q1 FY27).

What was Gujarat Kidney And Super Speciality Limited's net profit in Q1 FY27?